Juan Carlos
Galofre Ferrater
Consultor Médico
Instituto de Salud Carlos III
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Salud Carlos III (6)
2023
-
Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study
Frontiers in Endocrinology, Vol. 13
2020
-
Iodine nutrition status in Spain Needs for the future
Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 1, pp. 61-69
2019
-
Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes
Aging, Vol. 11, Núm. 6, pp. 1733-1744
2012
-
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity
International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294
-
Clinical usefulness of a new equation for estimating body fat
Diabetes Care, Vol. 35, Núm. 2, pp. 383-388
2011
-
Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI
Obesity, Vol. 19, Núm. 7, pp. 1439-1444